Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Feb 04 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/oxygenta-pharmaceutical-limited-press-release-feb-04-2025

Independent Directors Committee (IDC) have submitted to BSE recommendations under Regulation 26(7) of SEBI (SAST) Regulations, 2011, for the Open Offer to Public Shareholders of Oxygenta Pharmaceutical Ltd.

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases